Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10456-10461

  Yamaguchi, Yuko ^a   Harker, James A ^c   Wang, Belinda ^d   Openshaw, Peter J ^b   Tregoning, John S ^e   Culley, Fiona J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EXPOSURE; HELPER CELL; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NEONATAL RESPIRATORY SYNCYTIAL VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REINFECTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH1 CELL; VIRUS LOAD;

ANIMALS; ANTIGEN-PRESENTING CELLS; CPG ISLANDS; DNA METHYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT, NEWBORN; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; PREGNANCY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; TH1 CELLS; TOLL-LIKE RECEPTOR 9;

MUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

EID: 84869008952     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01082-12     Document Type: Article

References (35)

1. Adkins B, Du RQ. 1998. Newborn mice develop balanced Th1/Th2 primary effector responses in vivo but are biased to Th2 secondary responses. J. Immunol. 160:4217-4224.
2. Adkins B, LeClerc C, Marshall-Clarke S. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553-564.
3. Aksoy E, et al. 2007. Interferon regulatory factor 3-dependent responses to lipopolysaccharide are selectively blunted in cord blood cells. Blood 109:2887-2893.
4. Culley FJ, Pollott J, Openshaw PJ. 2002. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. Med. 196:1381-1386.
5. Danis B, et al. 2008. Interferon regulatory factor 7-mediated responses are defective in cord blood plasmacytoid dendritic cells. Eur. J. Immunol. 38:507-517.
6. de Brito C, et al. 2010. CpG-induced Th1-type response in the downmodulation of early development of allergy and inhibition of B7 expression on T cells of newborn mice. J. Clin. Immunol. 30:280-291.
7. Ege MJ, et al. 2006. Prenatal farm exposure is related to the expression of receptors of the innate immunity and to atopic sensitization in school-age children. J. Allergy Clin. Immunol. 117:817-823.
8. Genuneit J, et al. 2009. A multi-centre study of candidate genes for wheeze and allergy: the International Study of Asthma and Allergies in Childhood Phase 2. Clin. Exp. Allergy 39:1875-1888.
9. Goriely S, et al. 2001. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J. Immunol. 166:2141-2146.
10. Hannesdottir SG, Olafsdottir TA, Giudice GD, Jonsdottir I. 2008. Adjuvants LT-K63 and CpG enhance the activation of dendritic cells in neonatal mice. Scand. J. Immunol. 68:469-475.
11. Harker J, et al. 2007. Virally delivered cytokines alter the immune response to future lung infections. J. Virol. 81:13105-13111.
12. Harker JA, et al. 2010. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. J. Virol. 84:4073-4082.
13. Harker JA, et al. 2010. The delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. J. Virol. 84:5294-5302.
14. Hayashi T, Raz E. 2006. TLR9-based immunotherapy for allergic disease. Am. J. Med. 119:897.
15. Kovarik J, et al. 1999. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming. J. Immunol. 162: 1611-1617.
16. Kurt-Jones EA, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401.
17. Lee YM, et al. 2008. IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 177:208-218.
18. Levy O, et al. 2004. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173:4627-4634.
19. Liu AH, Leung DY. 2006. Renaissance of the hygiene hypothesis. J. Allergy Clin. Immunol. 117:1063-1066.
20. Marshall-Clarke S, Reen D, Tasker L, Hassan J. 2000. Neonatal immunity: how well has it grown up? Immunol. Today. 21:35-41.
21. Munir S, et al. 2011. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog. 7:e1001336. doi:10.1371/journal.ppat.1001336.
22. Ng MT, et al. 2010. Increase in NF-kappaB binding affinity of the variant C allele of the Toll-like receptor 9-1237T/C polymorphism is associated with Helicobacter pylori-induced gastric disease. Infect. Immun. 78:1345-1352.
23. Openshaw PJ, Tregoning JS. 2005. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 18:541-555.
24. Roux X, et al. 2011. Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells. Eur. J. Immunol. 41:2852-2861.
25. Roy SR, Schiltz AM, Marotta A, Shen Y, Liu AH. 2003. Bacterial DNA in house and farm barn dust. J. Allergy Clin. Immunol. 112:571-578.
26. Rudd BD, Burstein E, Duckett CS, Li X, Lukacs NW. 2005. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 79:3350-3357.
27. Sigurs N, et al. 2010. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 65:1045-1052.
28. Smit LAM, et al. 2009. CD14 and Toll-like receptor gene polymorphisms, country living, and asthma in adults. Am. J. Respir. Crit. Care Med. 179: 363-368.
29. Stein RT, et al. 1999. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354:541-545.
30. Sun CM, Deriaud E, LeClerc C, Lo-Man R. 2005. Upon TLR9 signaling, CD5+B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 22:467-477.
31. Tregoning JS, Schwarze J. 2010. Respiratory viral infections in infancy: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23:74-98.
32. Tregoning JS, Yamaguchi Y, Harker J, Wang B, Openshaw PJ. 2008. The role of T cells in the enhancement of RSV infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 82:4115-4124.
33. Tregoning JS, et al. 2010. Genetic susceptibility to the delayed sequelae of neonatal respiratory syncytial virus infection is MHC dependent. J. Immunol. 185:5384-5391.
34. Tregoning JS, et al. 2010. The chemokine MIP1a/CCL3 determines pathology in primary RSV infection by regulating the balance of T cell populations in the murine lung. PLoS One 5:e9381. doi:10.1371/ journal.pone.0009381.
35. Vercelli D. 2006. Mechanisms of the hygiene hypothesis-molecular and otherwise. Curr. Opin. Immunol. 18:733-737.